1. Analyst View
2. Diabetes Disease Indicator
3. Diabetes & Obesity
4. Global Market Analysis
4.1 Global Diabetes Drugs Market
4.2 Global Insulin Market
4.2.1 India
4.2.1.1 Prevalence
4.2.1.2 Market Analysis
4.2.2 China
4.2.2.1 Prevalence
4.2.2.2 Market Analysis
4.2.3 US
4.2.3.1 Prevalence
4.2.3.2 Market Analysis
4.2.4 Russia
4.2.4.1 Prevalence
4.2.4.2 Market Analysis
4.2.5 Japan
4.2.5.1 Prevalence
4.2.5.2 Market Analysis
4.2.6 Germany
4.2.6.1 Prevalence
4.2.6.2 Market Analysis
4.2.7 Pakistan
4.2.7.1 Prevalence
4.2.7.2 Market Analysis
4.2.8 Brazil
4.2.8.1 Prevalence
4.2.8.2 Market Analysis
4.2.9 Mexico
4.2.9.1 Prevalence
4.2.10 Egypt
4.2.10.1 Prevalence
5. Insulin Delivery Devices
5.1 Present Devices
5.1.1 Insulin Pens
5.1.1.1 Mechanism & Technologies
5.1.1.2 Market Analysis
5.1.1.2.1 Global
5.1.1.2.2 US
5.1.1.2.3 Europe
5.1.1.2.4 Japan
5.1.1.3 Pros & Cons
5.1.1.4 Key Players
5.1.2 Insulin Pumps
5.1.2.1 Mechanism & Technologies
5.1.2.2 Market Analysis
5.1.2.2.1 Global
5.1.2.2.2 US
5.1.2.2.3 Non US
5.1.2.3 Pros & Cons
5.1.2.4 Key Players
5.1.3 Inhaled Insulin
5.1.3.1 Mechanism & Technologies
5.1.3.2 Market Analysis
5.1.3.2.1 Exubera Lackluster Performance
5.1.3.2.2 Why Exubera Failed?
5.1.3.2.2.1 Poor Preparation for Product Launching
5.1.3.2.2.2 Insurance Reimbursements
5.1.3.2.2.3 Lack of Market Understanding for this Product
5.1.3.2.2.4 Effectiveness of Other Diabetes Treatments
5.1.3.2.2.5 Lack of Safety Data & Health-related Problems
5.1.3.2.2.6 Poor Design & Other Inconveniences
5.1.3.3 Pros & Cons
5.1.3.4 Projections & Future of Other Inhalable Insulin
5.1.4 Insulin Syringes
5.1.4.1 Mechanism & Technology
5.1.4.2 Market Analysis
5.1.4.3 Pros & Cons
5.1.4.4 Future Outlook (2007-2010)
5.1.5 Insulin Jet Injectors
5.1.5.1 Mechanism & Technologies
5.1.5.2 Market Analysis
5.1.5.3 Pros & Cons
5.1.5.4 Future Outlook (2007-2010)
5.2 Future Devices
5.2.1 Oral Insulin
5.2.2 Insulin Patch
5.2.3 Implantable Insulin Pumps
6. Industry Analysis
6.1 Drivers
6.1.1 Increasing Number of Diabetic Patients
6.1.2 Convenient & Less Painful Modes of Insulin Delivery
6.1.3 Improved Access & Lower Insulin Prices in the Developing World
6.1.4 Early Diagnosis & Increasing Awareness for Treatment
6.1.5 Government Support
6.2 Challenges
6.2.1 High R&D & Production Cost
6.2.2 Long Time to Market
6.2.3 Poverty
6.2.4 Insurance Reimbursement
6.2.5 Traditional Treatments
6.2.6 High Cost of Insulin Inhalers
6.2.7 Rapidly Changing Technology
6.3 Opportunities
6.3.1 US & Developing Countries - Potential Markets for Insulin Syringes
6.3.2 Europe & Japan - Potential Markets for Pen Devices
6.3.3 Developed World - Potential Market Oral Insulin
6.3.4 US - Potential Market for Insulin Pumps
7. Future Outlook
7.1 Global Diabetes Drug Market (2007-2012)
8. Key Players
8.1 Eli Lilly & Company
8.2 Novo Nordisk A/S
8.3 Sanofi-Aventis
8.4 Becton, Dickinson and Company
8.5 Medtronic, Inc.
.jpg)
